SCHEMBL6072906

SCHEMBL6072906

O=C(OC1C2CCC1CNC2)N1CCc2ccccc2C1c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 7/20 0.64
CHRM2 P08172 2/20 0.64
CHRM1 P11229 2/20 0.64
KCNH2 Q12809 2/20 0.64
CACNA1F O60840 1/20 0.64
CHRM4 P08173 1/20 0.64
CHRM5 P08912 1/20 0.64
KCNE1 P15382 1/20 0.64
KCNQ1 P51787 1/20 0.64
CACNA1D Q01668 1/20 0.64
CACNA1S Q13698 1/20 0.64
CACNA1C Q13936 1/20 0.64
SCN5A Q14524 1/20 0.64
KCND3 Q9UK17 1/20 0.64
HHAT Q5VTY9 3/20 0.48
CYP2D6 P10635 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22784213 0.92 CHRM3 (0.66) CHRM3CHRM2CHRM1KCNH2CACNA1F
SCHEMBL22776220 0.92 CHRM3 (0.66) CHRM3CHRM2CHRM1KCNH2CACNA1F
SCHEMBL22784225 0.92 CHRM3 (0.66) CHRM3CHRM2CHRM1KCNH2CACNA1F
SCHEMBL29560581 0.92 CHRM3 (0.66) CHRM3CHRM2CHRM1KCNH2CACNA1F
SCHEMBL22784543 0.83 CHRM3 (0.61) CHRM3CHRM2CHRM1KCNH2CACNA1F
SCHEMBL29560423 0.83 CHRM3 (0.61) CHRM3CHRM2CHRM1KCNH2CACNA1F
SCHEMBL6072890 0.82 CHRM3 (0.61) CHRM3CHRM2CHRM1KCNH2CACNA1F
SCHEMBL13041653 0.81 CHRM3 (0.64) CHRM3CHRM2CHRM1KCNH2CACNA1F
SCHEMBL13041638 0.81 CHRM3 (0.64) CHRM3CHRM2CHRM1KCNH2CACNA1F
SCHEMBL1567408 0.81 CHRM3 (0.64) CHRM3CHRM2CHRM1KCNH2CACNA1F

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006035280-A1 3,4-DIHYDROISOQUINOLINE COMPOUNDS AS MUSCRINIC RECEPTOR ANTAGONISTS FOR THE TREATMENT OF RESPIRATORY, URINARY AND GASTROINTESTINAL DISEASES RANBAXY LABORATORIES LIMITED (IN) 2006-04-06 WO claimed
WO-2006035280-A1 3,4-DIHYDROISOQUINOLINE COMPOUNDS AS MUSCRINIC RECEPTOR ANTAGONISTS FOR THE TREATMENT OF RESPIRATORY, URINARY AND GASTROINTESTINAL DISEASES RANBAXY LABORATORIES LIMITED (IN) 2006-04-06 WO disclosed